< BACK TO NEWS
importantSYS.SOURCE: TechCrunch• 2026-10-10T15:00:00Z

TechCrunch Disrupt 2026 Startup Showcase and Industry Insights

TechCrunch Disrupt 2026 will feature 300+ startups in its Expo Hall and 200+ sessions led by 250+ tech leaders, with opportunities to discover early-stage companies and access discounted event passes.

TechCrunch Disrupt 2026 takes place October 13-15 in San Francisco. Over 300 startups will show what they’ve built to 10,000 tech leaders. Plus, 250+ speakers are ready to share insights across 200+ sessions. Register before doors open to save up to $100 and get a second pass at 50% off.

Read original article

*** END OF TRANSMISSION ***

> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS> TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS> NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI> AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY> DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS> PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS> CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL> DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES> THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS> PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS> TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS> NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI> AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY> DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS> PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS> CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL> DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES> THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS> PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001